VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)
NCT00727753
·
clinicaltrials.gov ↗
COMPLETED
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Ranibizumab
DRUG:
Bevacizumab
OTHER:
No treatment
Sponsor
University of Zurich